European Penny Stocks To Consider In May 2025

In This Article:

As European markets show resilience with the pan-European STOXX Europe 600 Index rising by 3.44% amidst easing tariff concerns, investors are increasingly exploring diverse opportunities across the continent. Penny stocks, a term that may seem outdated, continue to capture interest due to their potential for significant value and growth within smaller or less-established companies. By focusing on financial strength and clear growth prospects, these stocks can offer investors a chance to uncover promising opportunities in Europe's evolving market landscape.

Top 10 Penny Stocks In Europe

Name

Share Price

Market Cap

Financial Health Rating

Transferator (NGM:TRAN A)

SEK2.66

SEK263.68M

★★★★★☆

Angler Gaming (NGM:ANGL)

SEK3.75

SEK281.19M

★★★★★★

Hifab Group (OM:HIFA B)

SEK3.48

SEK211.72M

★★★★★★

IMS (WSE:IMS)

PLN3.66

PLN124.05M

★★★★☆☆

AMSC (OB:AMSC)

NOK1.538

NOK110.53M

★★★★★★

Cellularline (BIT:CELL)

€2.58

€54.42M

★★★★★☆

Netgem (ENXTPA:ALNTG)

€0.995

€33.32M

★★★★★★

Fondia Oyj (HLSE:FONDIA)

€4.67

€17.46M

★★★★★★

Mistral Iberia Real Estate SOCIMI (BME:YMIB)

€1.01

€22.01M

★★★★★☆

Deceuninck (ENXTBR:DECB)

€2.13

€294.08M

★★★★★★

Click here to see the full list of 433 stocks from our European Penny Stocks screener.

Let's take a closer look at a couple of our picks from the screened companies.

Valbiotis

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Valbiotis SA focuses on the research and development of dietary supplements aimed at preventing metabolic and cardiovascular diseases in France, with a market cap of €17.88 million.

Operations: The company generates revenue from its Vitamins & Nutrition Products segment, amounting to €0.18 million.

Market Cap: €17.88M

Valbiotis SA, a pre-revenue biotech company with a market cap of €17.88 million, focuses on dietary supplements for metabolic and cardiovascular disease prevention. Despite having more cash than its total debt and seasoned management, the company faces financial challenges with less than a year of cash runway based on current free cash flow. Recent earnings showed a significant decrease in sales to €0.18 million from the previous year's €4.73 million, alongside an increased net loss of €10.03 million. While trading at 78.6% below estimated fair value, profitability remains elusive over the next three years according to forecasts.

ENXTPA:ALVAL Debt to Equity History and Analysis as at May 2025
ENXTPA:ALVAL Debt to Equity History and Analysis as at May 2025

Alpcot Holding

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Alpcot Holding AB (publ) operates a digital platform for personal finance in the financial industry in Sweden, with a market cap of approximately SEK144.57 million.